Regencell Bioscience Holdings Ltd (NASDAQ:RGC) does about 412.55K shares in volume on a normal day but saw 4817897 shares change hands in the recent trading day. The company now has a market cap of 164.22M USD. Its current market price is $12.62, marking a decrease of -10.43% compared to the previous close of $14.09. The 52 week high reached by this stock is $32.44 whilst the lowest price level in 52 weeks is $3.03.
Regencell Bioscience Holdings Ltd (RGC) has a 20-day trading average at $5.17 and the current price is -61.10% off the 52-week high compared with 316.50% distance from its 52-week low. The 50-day simple moving average of the closing price is $4.71 and its 200-day simple moving average is $5.80. If we look at the stock’s price movements over the week, volatility stands at 65.99%, which decreases to 22.66% over 1 month. It is also key to look at other market indicators of price movement for the stock, where we see that the relative strength index (RSI) is at 80.77 to suggest the stock is overbought.
The current price level is 144.27%, 167.71%, and 117.57% away from its SMA20, SMA50, and SMA200 respectively, with the RGC price moving below the 50-day SMA on current market day. Regencell Bioscience Holdings Ltd (RGC) stock is up 207.06% over the week and 237.43% over the past month. Its price is 155.47% year-to-date and 59.54% over the past year.
Outstanding shares total 13.01M with insiders holding 93.84% of the shares and institutional holders owning 0.29% of the company’s common stock. The company has a return on investment of -52.18% and return on equity of -42.49%. The beta has a value of -2.11. Price to book ratio is 19.98.
